Published in Int J Radiat Oncol Biol Phys on March 15, 2008
Standard chemoradiation for glioblastoma results in progressive brain volume loss. Neurology (2015) 2.72
Radiation-induced brain injury: A review. Front Oncol (2012) 1.91
Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology (2009) 1.26
Diffusion tensor imaging of normal-appearing white matter as biomarker for radiation-induced late delayed cognitive decline. Int J Radiat Oncol Biol Phys (2011) 1.08
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction. Clin Cancer Res (2009) 1.07
Reading impairment in a patient with missing arcuate fasciculus. Neuropsychologia (2008) 1.06
Regional variation in brain white matter diffusion index changes following chemoradiotherapy: a prospective study using tract-based spatial statistics. PLoS One (2013) 1.03
The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma†. Neuro Oncol (2015) 1.01
Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy study. J Magn Reson Imaging (2009) 1.00
Imaging radiation-induced normal tissue injury. Radiat Res (2012) 0.99
Radiation therapy effects on white matter fiber tracts of the limbic circuit. Med Phys (2012) 0.99
7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys (2011) 0.99
Brain irradiation: effects on normal brain parenchyma and radiation injury. Neuroimaging Clin N Am (2009) 0.96
Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma. Int J Radiat Oncol Biol Phys (2015) 0.95
Uncertainty in assessment of radiation-induced diffusion index changes in individual patients. Phys Med Biol (2013) 0.92
Differences in brainstem fiber tract response to radiation: a longitudinal diffusion tensor imaging study. Int J Radiat Oncol Biol Phys (2013) 0.91
Brain tumor therapy-induced changes in normal-appearing brainstem measured with longitudinal diffusion tensor imaging. Int J Radiat Oncol Biol Phys (2011) 0.90
Reduced fractional anisotropy and axial diffusivity in white matter in 22q11.2 deletion syndrome: a pilot study. Schizophr Res (2012) 0.86
Differential effects of radiation and age on diffusion tensor imaging in rats. Brain Res (2010) 0.84
Dose-dependent white matter damage after brain radiotherapy. Radiother Oncol (2016) 0.83
Neuroimaging and neuropsychological follow-up study in a pediatric brain tumor patient treated with surgery and radiation. Neurocase (2010) 0.82
Clinical applications for diffusion magnetic resonance imaging in radiotherapy. Semin Radiat Oncol (2014) 0.81
Differential expression of Homer1a in the hippocampus and cortex likely plays a role in radiation-induced brain injury. Radiat Res (2013) 0.80
Effect of the Maximum Dose on White Matter Fiber Bundles Using Longitudinal Diffusion Tensor Imaging. Int J Radiat Oncol Biol Phys (2016) 0.80
Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma. Semin Radiat Oncol (2014) 0.79
Biologically conformal treatment: biomarkers and functional imaging in radiation oncology. Future Oncol (2008) 0.79
Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol (2016) 0.79
Whole-brain changes in white matter microstructure after radiotherapy for nasopharyngeal carcinoma: a diffusion tensor imaging study. Eur Arch Otorhinolaryngol (2016) 0.76
Effects of Surgery and Proton Therapy on Cerebral White Matter of Craniopharyngioma Patients. Int J Radiat Oncol Biol Phys (2015) 0.76
Preoperative weakness and demyelination of the corticospinal tract in meningioma patients : changes in diffusion parameters using diffusion tensor imaging. J Korean Neurosurg Soc (2014) 0.75
Regional susceptibility to dose-dependent white matter damage after brain radiotherapy. Radiother Oncol (2017) 0.75
Diffusion tensor imaging profiles reveal specific neural tract distortion in normal pressure hydrocephalus. PLoS One (2017) 0.75
Long-term effects of radiation therapy on white matter of the corpus callosum: a diffusion tensor imaging study in children. Pediatr Radiol (2017) 0.75
Development of cystic malacia after high-dose cranial irradiation of pediatric CNS tumors in long-term follow-up. Childs Nerv Syst (2017) 0.75
Characteristic diffusion tensor tractography in multiple system atrophy with predominant cerebellar ataxia and cortical cerebellar atrophy. J Neurol (2016) 0.75
Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage (2002) 11.37
Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med (1996) 10.50
Diffusion tensor MR imaging of the human brain. Radiology (1996) 9.84
Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage (2003) 8.47
Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage (2005) 7.24
Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med (2000) 3.58
A simplified method to measure the diffusion tensor from seven MR images. Magn Reson Med (1998) 3.49
Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med (2006) 2.90
Normal brain maturation during childhood: developmental trends characterized with diffusion-tensor MR imaging. Radiology (2001) 2.78
Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys (1995) 2.50
Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys (1980) 2.33
The radioresponse of the central nervous system: a dynamic process. Radiat Res (2000) 2.10
Diffuse axonal injury in head trauma. J Head Trauma Rehabil (2005) 2.09
Brain dysmyelination and recovery assessment by noninvasive in vivo diffusion tensor magnetic resonance imaging. J Neurosci Res (2006) 2.05
Current concepts: diffuse axonal injury-associated traumatic brain injury. Arch Phys Med Rehabil (2001) 1.92
White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol (2006) 1.66
Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys (2007) 1.65
Radiation injury of the brain. AJNR Am J Neuroradiol (1991) 1.62
Neurological complications of radiotherapy and chemotherapy. J Neurol (1998) 1.56
Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel index and the Functional Independence Measure. J Neurol Neurosurg Psychiatry (1999) 1.54
Time- and dose-related changes in the white matter of the rat brain after single doses of X rays. Br J Radiol (1988) 1.40
The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer (1979) 1.36
Cerebral radiation necrosis following treatment of extracranial malignancies. Cancer (1984) 1.19
Differentiation between dysmyelination and demyelination using magnetic resonance diffusional anisotropy. Brain Res (1995) 1.16
Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys (2000) 1.14
Development of blood vessel-related radiation damage in the fimbria of the central nervous system. Int J Radiat Oncol Biol Phys (1990) 1.12
Radiation-induced astrocytic and microglial responses in mouse brain. Radiother Oncol (1993) 1.06
Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys (1988) 1.06
Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Disabil Res Rev (2006) 1.05
Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer (1986) 0.99
White matter anisotropy in childhood medulloblastoma survivors: association with neurotoxicity risk factors. Radiology (2005) 0.96
Radiosensitivities of nervous tissues. Brookhaven Symp Biol (1961) 0.95
Radiation effects on the human central nervous system 14 weeks after x-radiation. Acta Neuropathol (1968) 0.92
Demyelinization induced in the brains of monkeys by means of fast neutrons; pathogenesis of the lesion and comparison with the lesions of multiple sclerosis and Schilder's disease. J Exp Med (1956) 0.88
Radiotherapeutic effects on brain function: double dissociation of memory systems. Neuropsychiatry Neuropsychol Behav Neurol (2000) 0.87
Late radiation effects in the dog brain: correlation of MRI and histological changes. Radiother Oncol (2002) 0.86
Radiation-induced morphologic changes in the rhesus monkey (Macaca mulatta) brain. J Med Primatol (2001) 0.84
Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia. J Neurol Sci (2004) 0.83
MRI and PET of delayed heavy-ion radiation injury in the rabbit brain. Int J Radiat Oncol Biol Phys (1991) 0.80
Cerebral blood flow in patients with diffuse axonal injury--examination of the easy Z-score imaging system utility. Eur J Neurol (2007) 0.79
The pathogenesis of radiation myelopathy: widening the circle. Int J Radiat Oncol Biol Phys (1992) 0.77
Myelin basic protein and magnetic resonance imaging for diagnosing radiation myelopathy. Int J Radiat Oncol Biol Phys (1988) 0.77
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (2011) 5.53
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A (2005) 4.63
Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med (2010) 4.15
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One (2009) 3.66
Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys (2002) 3.64
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol (2008) 3.55
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys (2006) 3.40
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A (2005) 3.15
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials (2007) 3.12
Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med (2012) 2.95
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol (2010) 2.90
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol (2008) 2.84
Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience. Radiology (2005) 2.69
It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging (2002) 2.58
Towards hyperpolarized (13)C-succinate imaging of brain cancer. J Magn Reson (2007) 2.57
Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology (2012) 2.53
Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res (2006) 2.46
Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells. Eur Urol (2007) 2.42
Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol (2007) 2.39
Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer Res (2010) 2.34
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2007) 2.33
The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med (2009) 2.32
An ER-fMRI investigation of morphological inflection in German reveals that the brain makes a distinction between regular and irregular forms. Brain Lang (2003) 2.30
The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia (2006) 2.30
Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther (2003) 2.28
PASADENA hyperpolarization of succinic acid for MRI and NMR spectroscopy. J Am Chem Soc (2008) 2.27
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol (2005) 2.20
A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol (2009) 2.10
Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A (2002) 1.93
The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards. J Clin Oncol (2009) 1.88
Integration of EGFR inhibitors with radiochemotherapy. Nat Rev Cancer (2006) 1.83
Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging (2010) 1.82
Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. Int J Radiat Oncol Biol Phys (2005) 1.79
Bayesian hierarchical changepoint methods in modeling the tumor growth profiles in xenograft experiments. Clin Cancer Res (2010) 1.75
Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo. Clin Cancer Res (2004) 1.74
Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci (2003) 1.72
The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer. Clin Cancer Res (2008) 1.68
Molecular imaging of Akt kinase activity. Nat Med (2007) 1.68
Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells. Mol Cancer Ther (2009) 1.66
Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev (2006) 1.66
Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine. Cancer Res (2005) 1.64
A methodology for registration of a histological slide and in vivo MRI volume based on optimizing mutual information. Mol Imaging (2006) 1.63
Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions. AJR Am J Roentgenol (2009) 1.61
Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom. J Magn Reson Imaging (2012) 1.57
PASADENA hyperpolarization of 13C biomolecules: equipment design and installation. MAGMA (2008) 1.56
Comparing cortical activations for silent and overt speech using event-related fMRI. Hum Brain Mapp (2002) 1.56
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol (2007) 1.55
Hyperpolarized water as an MR imaging contrast agent: feasibility of in vivo imaging in a rat model. Radiology (2012) 1.54
Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. J Clin Oncol (2005) 1.54
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Semin Oncol (2005) 1.53
Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging (2002) 1.53
Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor. J Cereb Blood Flow Metab (2006) 1.51
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia (2007) 1.50
Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies. J Magn Reson Imaging (2011) 1.50
Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma. Clin Cancer Res (2007) 1.48
The application of lean thinking to the care of patients with bone and brain metastasis with radiation therapy. J Oncol Pract (2007) 1.48
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci U S A (2005) 1.44
An anaphylactoid reaction from amifostine. Radiother Oncol (2006) 1.42
Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker. Clin Cancer Res (2004) 1.42
Quality assurance of PASADENA hyperpolarization for 13C biomolecules. MAGMA (2008) 1.41
Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magn Reson Imaging (2006) 1.40
Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res (2011) 1.39
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res (2014) 1.39
Radiotherapy for locally advanced pancreatic cancer. J Clin Oncol (2007) 1.38
Diffusion imaging for therapy response assessment of brain tumor. Neuroimaging Clin N Am (2009) 1.38
Real-time molecular imaging of tricarboxylic acid cycle metabolism in vivo by hyperpolarized 1-(13)C diethyl succinate. J Am Chem Soc (2011) 1.36
Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res (2006) 1.34
Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution. Int J Radiat Oncol Biol Phys (2009) 1.34